Article Versions Notes

Morales LC, Modi L, Abbasi Dezfouli S, Rajendran AP, Kc R, Kadam V, Sipione S, Uludağ H. In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington’s Disease. Pharmaceutics. 2025; 17(6):726. https://doi.org/10.3390/pharmaceutics17060726

Morales, Luis C., Luv Modi, Saba Abbasi Dezfouli, Amarnath Praphakar Rajendran, Remant Kc, Vaibhavi Kadam, Simonetta Sipione, and Hasan Uludağ. 2025. "In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington’s Disease" Pharmaceutics 17, no. 6: 726. https://doi.org/10.3390/pharmaceutics17060726

Morales, L. C., Modi, L., Abbasi Dezfouli, S., Rajendran, A. P., Kc, R., Kadam, V., Sipione, S., & Uludağ, H. (2025). In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington’s Disease. Pharmaceutics, 17(6), 726. https://doi.org/10.3390/pharmaceutics17060726